Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 10-Q Report Quarterly Report
  2. 4/A Grant or award CFO and CBO acquired 25,000 shares (grant or award)
  3. 4 Grant or award CFO and CBO acquired 25,000 shares (grant or award)
  4. 4 Grant or award President and Chief Executive acquired 200,000 shares (grant or award)
  5. 4 Grant or award Chief Operating Officer acquired 110,000 shares (grant or award)
  6. 8-K Event Executive or director change
  7. SC TO-I/A Deal Tender Offer Statement by Issuer
  8. SC TO-C Deal Written Communication Relating to an Issuer
  9. 8-K Event Other events
  10. SC TO-I Deal Tender Offer Statement by Issuer
  11. 8-K Event Other events
  12. 4 Grant or award Director acquired 15,000 shares (grant or award)
  13. 4 Planned sale CFO and CBO sold 1,960 shares at $11.41 ($22,368)
  14. 4 Grant or award Director acquired 9,000 shares (grant or award)
  15. 4 Grant or award Director acquired 9,000 shares (grant or award)
  16. 4 Grant or award Director acquired 9,000 shares (grant or award)
  17. 4 Grant or award Director acquired 9,000 shares (grant or award)
  18. 4 Grant or award Director acquired 9,000 shares (grant or award)
  19. 4 Grant or award Director acquired 9,000 shares (grant or award)
  20. 4 Grant or award Director acquired 9,000 shares (grant or award)

Page 11 of 25 · 496 filings